Sentence	entity_1	entity_2	entity_3	entity_4	entity_5	entity_6	entity_7	entity_8	entity_9	entity_10	entity_11	entity_12	entity_13	entity_14	entity_15	entity_16	json	split
We here report that ( i) like PML - RAR alpha expression, PLZF - RAR alpha expression blocks terminal differentiation of hematopoietic precursor cell lines ( U937 and HL - 60) in response to different stimuli ( vitamin D3, transforming growth factor beta1, and dimethyl sulfoxide); ( ii) PML - RAR alpha, but not PLZF - RAR alpha, increases RA sensitivity of hematopoietic precursor cells and restores RA sensitivity of RA - resistant hematopoietic cells; ( iii) PML - RAR alpha and PLZF - RAR alpha have similar RA binding affinities; and ( iv) PML - RAR alpha enhances the RA response of RA target genes ( those for RAR beta, RAR gamma, and transglutaminase type II [ TGase]) in vivo, while PLZF - RAR alpha expression has either no effect ( RAR beta) or an inhibitory activity ( RAR gamma and type II TGase).	PML - RAR alpha,30,45,Gene/Protein	PLZF - RAR alpha,58,74,Gene/Protein	PML - RAR alpha,288,303,Gene/Protein	PLZF - RAR alpha,313,329,Gene/Protein	PML - RAR alpha,463,478,Gene/Protein	PLZF - RAR alpha,483,499,Gene/Protein	PML - RAR alpha,546,561,Gene/Protein	RA target genes,590,605,Gene/Protein	RAR beta,618,626,Gene/Protein	RAR gamma,628,637,Gene/Protein	transglutaminase type II,643,667,Gene/Protein	TGase,670,675,Gene/Protein	PLZF - RAR alpha,693,709,Gene/Protein	RAR beta,744,752,Gene/Protein	RAR gamma,782,791,Gene/Protein	type II TGase,796,809,Gene/Protein	"[{""token"": ""PML - RAR alpha"", ""start_span"": 30, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""PLZF - RAR alpha"", ""start_span"": 58, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""PML - RAR alpha"", ""start_span"": 288, ""end_span"": 303, ""type"": ""Gene/Protein""}, {""token"": ""PLZF - RAR alpha"", ""start_span"": 313, ""end_span"": 329, ""type"": ""Gene/Protein""}, {""token"": ""PML - RAR alpha"", ""start_span"": 463, ""end_span"": 478, ""type"": ""Gene/Protein""}, {""token"": ""PLZF - RAR alpha"", ""start_span"": 483, ""end_span"": 499, ""type"": ""Gene/Protein""}, {""token"": ""PML - RAR alpha"", ""start_span"": 546, ""end_span"": 561, ""type"": ""Gene/Protein""}, {""token"": ""RA target genes"", ""start_span"": 590, ""end_span"": 605, ""type"": ""Gene/Protein""}, {""token"": ""RAR beta"", ""start_span"": 618, ""end_span"": 626, ""type"": ""Gene/Protein""}, {""token"": ""RAR gamma"", ""start_span"": 628, ""end_span"": 637, ""type"": ""Gene/Protein""}, {""token"": ""transglutaminase type II"", ""start_span"": 643, ""end_span"": 667, ""type"": ""Gene/Protein""}, {""token"": ""TGase"", ""start_span"": 670, ""end_span"": 675, ""type"": ""Gene/Protein""}, {""token"": ""PLZF - RAR alpha"", ""start_span"": 693, ""end_span"": 709, ""type"": ""Gene/Protein""}, {""token"": ""RAR beta"", ""start_span"": 744, ""end_span"": 752, ""type"": ""Gene/Protein""}, {""token"": ""RAR gamma"", ""start_span"": 782, ""end_span"": 791, ""type"": ""Gene/Protein""}, {""token"": ""type II TGase"", ""start_span"": 796, ""end_span"": 809, ""type"": ""Gene/Protein""}]"	train
Our results demonstrated that: ( i) PGN induced phosphorylation of the transcription factors ATF - 1 and CREB; ( ii) ATF - 1 and CREB bound DNA as a dimer and induced transcriptional activation of a CRE reporter plasmid, which was inhibited by dominant negative CREB and ATF - 1; ( iii) PGN induced phosphorylation of c - Jun, protein synthesis of JunB and c - Fos, and transcriptional activation of the AP - 1 reporter plasmid, which was inhibited by dominant negative c - Fos; and ( iv) PGN - induced activation of CREB / ATF and AP - 1 was mediated through CD14.	transcription factors,71,92,Gene/Protein	ATF - 1,93,100,Gene/Protein	CREB,105,109,Gene/Protein	ATF - 1,117,124,Gene/Protein	CREB,129,133,Gene/Protein	CRE reporter plasmid,199,219,Gene/Protein	CREB,262,266,Gene/Protein	ATF - 1,271,278,Gene/Protein	c - Jun,318,325,Gene/Protein	JunB,348,352,Gene/Protein	c - Fos,357,364,Gene/Protein	AP - 1 reporter plasmid,404,427,Gene/Protein	c - Fos,470,477,Gene/Protein	CREB / ATF,517,527,Gene/Protein	AP - 1,532,538,Gene/Protein	CD14,560,564,Gene/Protein	"[{""token"": ""transcription factors"", ""start_span"": 71, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""ATF - 1"", ""start_span"": 93, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""CREB"", ""start_span"": 105, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""ATF - 1"", ""start_span"": 117, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""CREB"", ""start_span"": 129, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""CRE reporter plasmid"", ""start_span"": 199, ""end_span"": 219, ""type"": ""Gene/Protein""}, {""token"": ""CREB"", ""start_span"": 262, ""end_span"": 266, ""type"": ""Gene/Protein""}, {""token"": ""ATF - 1"", ""start_span"": 271, ""end_span"": 278, ""type"": ""Gene/Protein""}, {""token"": ""c - Jun"", ""start_span"": 318, ""end_span"": 325, ""type"": ""Gene/Protein""}, {""token"": ""JunB"", ""start_span"": 348, ""end_span"": 352, ""type"": ""Gene/Protein""}, {""token"": ""c - Fos"", ""start_span"": 357, ""end_span"": 364, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1 reporter plasmid"", ""start_span"": 404, ""end_span"": 427, ""type"": ""Gene/Protein""}, {""token"": ""c - Fos"", ""start_span"": 470, ""end_span"": 477, ""type"": ""Gene/Protein""}, {""token"": ""CREB / ATF"", ""start_span"": 517, ""end_span"": 527, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 532, ""end_span"": 538, ""type"": ""Gene/Protein""}, {""token"": ""CD14"", ""start_span"": 560, ""end_span"": 564, ""type"": ""Gene/Protein""}]"	valid
We here report that ( i) like PML - RAR alpha expression, PLZF - RAR alpha expression blocks terminal differentiation of hematopoietic precursor cell lines ( U937 and HL - 60) in response to different stimuli ( vitamin D3, transforming growth factor beta1, and dimethyl sulfoxide); ( ii) PML - RAR alpha, but not PLZF - RAR alpha, increases RA sensitivity of hematopoietic precursor cells and restores RA sensitivity of RA - resistant hematopoietic cells; ( iii) PML - RAR alpha and PLZF - RAR alpha have similar RA binding affinities; and ( iv) PML - RAR alpha enhances the RA response of RA target genes ( those for RAR beta, RAR gamma, and transglutaminase type II [ TGase]) in vivo, while PLZF - RAR alpha expression has either no effect ( RAR beta) or an inhibitory activity ( RAR gamma and type II TGase).	PML - RAR alpha,30,45,Gene/Protein	PLZF - RAR alpha,58,74,Gene/Protein	PML - RAR alpha,288,303,Gene/Protein	PLZF - RAR alpha,313,329,Gene/Protein	PML - RAR alpha,463,478,Gene/Protein	PLZF - RAR alpha,483,499,Gene/Protein	PML - RAR alpha,546,561,Gene/Protein	RA target genes,590,605,Gene/Protein	RAR beta,618,626,Gene/Protein	RAR gamma,628,637,Gene/Protein	transglutaminase type II,643,667,Gene/Protein	TGase,670,675,Gene/Protein	PLZF - RAR alpha,693,709,Gene/Protein	RAR beta,744,752,Gene/Protein	RAR gamma,782,791,Gene/Protein	type II TGase,796,809,Gene/Protein	"[{""token"": ""PML - RAR alpha"", ""start_span"": 30, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""PLZF - RAR alpha"", ""start_span"": 58, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""PML - RAR alpha"", ""start_span"": 288, ""end_span"": 303, ""type"": ""Gene/Protein""}, {""token"": ""PLZF - RAR alpha"", ""start_span"": 313, ""end_span"": 329, ""type"": ""Gene/Protein""}, {""token"": ""PML - RAR alpha"", ""start_span"": 463, ""end_span"": 478, ""type"": ""Gene/Protein""}, {""token"": ""PLZF - RAR alpha"", ""start_span"": 483, ""end_span"": 499, ""type"": ""Gene/Protein""}, {""token"": ""PML - RAR alpha"", ""start_span"": 546, ""end_span"": 561, ""type"": ""Gene/Protein""}, {""token"": ""RA target genes"", ""start_span"": 590, ""end_span"": 605, ""type"": ""Gene/Protein""}, {""token"": ""RAR beta"", ""start_span"": 618, ""end_span"": 626, ""type"": ""Gene/Protein""}, {""token"": ""RAR gamma"", ""start_span"": 628, ""end_span"": 637, ""type"": ""Gene/Protein""}, {""token"": ""transglutaminase type II"", ""start_span"": 643, ""end_span"": 667, ""type"": ""Gene/Protein""}, {""token"": ""TGase"", ""start_span"": 670, ""end_span"": 675, ""type"": ""Gene/Protein""}, {""token"": ""PLZF - RAR alpha"", ""start_span"": 693, ""end_span"": 709, ""type"": ""Gene/Protein""}, {""token"": ""RAR beta"", ""start_span"": 744, ""end_span"": 752, ""type"": ""Gene/Protein""}, {""token"": ""RAR gamma"", ""start_span"": 782, ""end_span"": 791, ""type"": ""Gene/Protein""}, {""token"": ""type II TGase"", ""start_span"": 796, ""end_span"": 809, ""type"": ""Gene/Protein""}]"	train
Our results demonstrated that: ( i) PGN induced phosphorylation of the transcription factors ATF - 1 and CREB; ( ii) ATF - 1 and CREB bound DNA as a dimer and induced transcriptional activation of a CRE reporter plasmid, which was inhibited by dominant negative CREB and ATF - 1; ( iii) PGN induced phosphorylation of c - Jun, protein synthesis of JunB and c - Fos, and transcriptional activation of the AP - 1 reporter plasmid, which was inhibited by dominant negative c - Fos; and ( iv) PGN - induced activation of CREB / ATF and AP - 1 was mediated through CD14.	transcription factors,71,92,Gene/Protein	ATF - 1,93,100,Gene/Protein	CREB,105,109,Gene/Protein	ATF - 1,117,124,Gene/Protein	CREB,129,133,Gene/Protein	CRE reporter plasmid,199,219,Gene/Protein	CREB,262,266,Gene/Protein	ATF - 1,271,278,Gene/Protein	c - Jun,318,325,Gene/Protein	JunB,348,352,Gene/Protein	c - Fos,357,364,Gene/Protein	AP - 1 reporter plasmid,404,427,Gene/Protein	c - Fos,470,477,Gene/Protein	CREB / ATF,517,527,Gene/Protein	AP - 1,532,538,Gene/Protein	CD14,560,564,Gene/Protein	"[{""token"": ""transcription factors"", ""start_span"": 71, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""ATF - 1"", ""start_span"": 93, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""CREB"", ""start_span"": 105, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""ATF - 1"", ""start_span"": 117, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""CREB"", ""start_span"": 129, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""CRE reporter plasmid"", ""start_span"": 199, ""end_span"": 219, ""type"": ""Gene/Protein""}, {""token"": ""CREB"", ""start_span"": 262, ""end_span"": 266, ""type"": ""Gene/Protein""}, {""token"": ""ATF - 1"", ""start_span"": 271, ""end_span"": 278, ""type"": ""Gene/Protein""}, {""token"": ""c - Jun"", ""start_span"": 318, ""end_span"": 325, ""type"": ""Gene/Protein""}, {""token"": ""JunB"", ""start_span"": 348, ""end_span"": 352, ""type"": ""Gene/Protein""}, {""token"": ""c - Fos"", ""start_span"": 357, ""end_span"": 364, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1 reporter plasmid"", ""start_span"": 404, ""end_span"": 427, ""type"": ""Gene/Protein""}, {""token"": ""c - Fos"", ""start_span"": 470, ""end_span"": 477, ""type"": ""Gene/Protein""}, {""token"": ""CREB / ATF"", ""start_span"": 517, ""end_span"": 527, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 532, ""end_span"": 538, ""type"": ""Gene/Protein""}, {""token"": ""CD14"", ""start_span"": 560, ""end_span"": 564, ""type"": ""Gene/Protein""}]"	train
